Trial Profile
A phase III trial of lopixibat-chloride in Alagille syndrome
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2018
Price :
$35
*
At a glance
- Drugs Maralixibat (Primary)
- Indications Alagille syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Mirum Pharmaceuticals
- 17 Nov 2018 New trial record
- 07 Nov 2018 According to a Mirum Pharmaceuticals media release , the company plans to initiate this trial in 2019